Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse
dc.contributor.author | Fantegrossi, William E. | en_US |
dc.contributor.author | Garza, Richard | en_US |
dc.contributor.author | Kiessel, Christina Lynn | en_US |
dc.contributor.author | Woods, James H. | en_US |
dc.date.accessioned | 2006-09-11T17:41:58Z | |
dc.date.available | 2006-09-11T17:41:58Z | |
dc.date.issued | 2005-09 | en_US |
dc.identifier.citation | Fantegrossi, William E.; Kiessel, Christina L.; Garza, Richard; Woods, James H.; (2005). "Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse." Psychopharmacology 181(3): 529-536. <http://hdl.handle.net/2027.42/46368> | en_US |
dc.identifier.issn | 0033-3158 | en_US |
dc.identifier.issn | 1432-2072 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/46368 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15983787&dopt=citation | en_US |
dc.description.abstract | Drug challenges in “intact” and p -chlorophenylalanine ( p -CPA)-treated animals can be used to distinguish agents that act as direct serotonin (5-HT) agonists from agents that function as 5-HT releasers. | en_US |
dc.format.extent | 246566 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Springer-Verlag | en_US |
dc.subject.other | Locomotor Activity | en_US |
dc.subject.other | P -CPA | en_US |
dc.subject.other | Hyperthermia | en_US |
dc.subject.other | Head Twitch Response | en_US |
dc.title | Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan Medical School, 1301 MSRB III, 1150 West Medical Center Drive, Ann Arbor, MI, 48109-0632, USA, | en_US |
dc.contributor.affiliationum | Division of Neuroscience, Yerkes National Primate Research Center, Emory University, 954 Gatewood Drive, Atlanta, GA, 30322, USA, ; Department of Pharmacology, University of Michigan Medical School, 1301 MSRB III, 1150 West Medical Center Drive, Ann Arbor, MI, 48109-0632, USA, | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan Medical School, 1301 MSRB III, 1150 West Medical Center Drive, Ann Arbor, MI, 48109-0632, USA, | en_US |
dc.contributor.affiliationother | Department of Psychiatry, Neuropsychiatric Institute, A8-148, University of California Los Angeles, Los Angeles, CA, 90024, USA, | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 15983787 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/46368/1/213_2005_Article_5.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/s00213-005-0005-8 | en_US |
dc.identifier.source | Psychopharmacology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.